Cantharidin-manganese based cocktail nanoplatform Co-activating ferroptosis and STING for enhanced HCC immunotherapy

Shengmei Wang, Mengtian Ma, Qiuyan Guo, Guiming Deng, Xinhua Xia, Jianyu Li, Xueqing Tao, Dong Zhong, Kun Zhang · 2026

Read Cantharidin-manganese based cocktail nanoplatform Co-activating ferroptosis and STING for enhanced HCC immunotherapy by Shengmei Wang, Mengtian Ma, Qiuyan Guo, Guiming Deng, Xinhua Xia, Jianyu Li, Xueqing Tao, Dong Zhong, Kun Zhang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13332119.txt.

Description

Shengmei Wang and colleagues built a combined nanoparticle treatment for liver cancer in 2026 laboratory work. Liver cancer is usually found late, and immunotherapy often fails because the tumor surroundings suppress immune attack.

Their one-pot platform loads cantharidin, a chemotherapy drug, together with manganese ions into albumin particles. Inside tumor cells the pair raises reactive oxygen sharply, driving an iron-dependent cell death called ferroptosis and releasing alarm signals that mature dendritic cells. Manganese also sharpens the cGAS-STING alarm pathway, which the drug's DNA damage triggers, boosting type I interferon output. In mice the treatment curbed tumor growth and spread, lengthened survival, and worked even better alongside an anti-PD-L1 antibody. The design also avoids the kidney and liver harm of free cantharidin and the poor tumor reach of free manganese.

Catalog record

CREATORShengmei Wang, Mengtian Ma, Qiuyan Guo, Guiming Deng, Xinhua Xia, Jianyu Li, Xueqing Tao, Dong Zhong, Kun Zhang
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE87857
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13332119

Browse the full library · About the Tower of Babel